Related references
Note: Only part of the references are listed.Beyond natural antibodies: the power of in vitro display technologies
Andrew R. M. Bradbury et al.
NATURE BIOTECHNOLOGY (2011)
High Affinity Antigen Recognition of the Dual Specific Variants of Herceptin Is Entropy-Driven in Spite of Structural Plasticity
Jenny Bostrom et al.
PLOS ONE (2011)
Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma
M. Bendandi et al.
ANNALS OF ONCOLOGY (2010)
Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems
Gregory P. Pogue et al.
PLANT BIOTECHNOLOGY JOURNAL (2010)
Inhibition of Toxic Shock by Human Monoclonal Antibodies against Staphylococcal Enterotoxin B
Eileen A. Larkin et al.
PLOS ONE (2010)
Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure
Richard Strasser et al.
PLANT BIOTECHNOLOGY JOURNAL (2008)
High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries
Frederic A. Fellouse et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets
Victor Nizet
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Antibody internalization studied using a novel IgG binding toxin fusion
Yariv Mazor et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Identifying specificity profiles for peptide recognition modules from phage-displayed peptide libraries
Raffi Tonikian et al.
NATURE PROTOCOLS (2007)
Synthetic therapeutic antibodies
Sachdev S. Sidhu et al.
NATURE CHEMICAL BIOLOGY (2006)
Staphylococcal innate immune evasion
SHM Rooijakkers et al.
TRENDS IN MICROBIOLOGY (2005)
Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants
S Marillonnet et al.
NATURE BIOTECHNOLOGY (2005)
The evolving field of biodefence: Therapeutic developments and diagnostics
JC Burnett et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens:: Implications for therapy of toxic shock syndrome
J Darenberg et al.
CLINICAL INFECTIOUS DISEASES (2004)
Identification of differences in the specificity-determining residues of antibodies that recognize antigens of different size: implications for the rational design of antibody repertoires
JC Almagro
JOURNAL OF MOLECULAR RECOGNITION (2004)
Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome:: A European randomized, double-blind, placebo-controlled trial
J Darenberg et al.
CLINICAL INFECTIOUS DISEASES (2003)
Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis
FF Vajdos et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Production and purification of a recombinant staphylococcal enterotoxin B vaccine candidate expressed in Escherichia coli
JD Coffman et al.
PROTEIN EXPRESSION AND PURIFICATION (2002)
Toxic shock syndrome and bacterial superantigens: An update
JK McCormick et al.
ANNUAL REVIEW OF MICROBIOLOGY (2001)
Diversity in the CDR3 region of VH is sufficient for most antibody specificities
JL Xu et al.
IMMUNITY (2000)
Exotoxins of Staphylococcus aureus
MM Dinges et al.
CLINICAL MICROBIOLOGY REVIEWS (2000)
Share Paper
